Header Logo

Connection

HUSSEIN TAWBI to Hematologic Diseases

Back to Details
This is a "connection" page, showing publications HUSSEIN TAWBI has written about Hematologic Diseases.
HUSSEIN TAWBI
Connection Strength
0.034
Hematologic Diseases
  1. Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial. Lancet Oncol. 2017 08; 18(8):1089-1103.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.